Market by Product, Technology, Application, Industry Vertical, and Country Outlook | Forecast 2021-2028
As per Triton’s report, the
Middle East and Africa DNA sequencing market is anticipated to progress with a
CAGR of 15.78% over the forecasting duration between 2021 and 2028.
Report scope can be customized per your requirements. Request For Customization
The countries scrutinized in
the market in this region include:
• The United Arab Emirates
• South Africa
• Saudi Arabia
• Turkey
• Rest of MEA countries
Estimates from the World Bank
suggest that, in 2018, the United Arab Emirates spent 1.303% of its total GDP
on research and development activities, a substantial rise from the preceding
years. The growing research and development is expected to positively impact
the overall market growth. Moreover, in October 2020, Abu Dhabi’s International
Holdings Company (IHC), invested around GBP 39 million in the DNA sequencing
technology company Oxford Nanopore Technologies, which is considered a pioneer
in the field. Along with supporting the manufacturing and commercial operations,
IHC is also supporting COVID-19 testing capabilities. Such initiatives are
expected to create greater opportunities for the development of the DNA
sequencing market in the country in the coming years.
People in Saudi Arabia have a
high predisposition to genetic diseases, which is mostly due to the high rate
of marriage among relatives. To tackle this rising concern, the country
launched the Saudi Genome Program in 2013. The implementation of this program significantly
raised the adoption of DNA sequencing technology in the Kingdom. This program
has helped reduce and prevent genetic diseases with the implementation of
reliable methods for screening and detection. Besides, the program has also
created the necessary physical and legislative infrastructure required for the
adoption and development of personalized medicine. This is a gigantic medical
leap taken by the country to detect the genes responsible for genetic diseases among
people. Such initiatives are significantly contributing to the DNA sequencing market’s
growth.
Siemens Healthineers AG is a
leading medical technology company. It manufactures surgical, medical,
ophthalmic, and veterinary apparatus and instruments with diagnostics, full-spectrum
imaging, advanced therapies, and services. The TRUGENE HIV-1 Genotyping Assay,
manufactured by the company, runs on the OpenGene DNA System, and is known to
provide the most clinically relevant information to monitor the resistance to
HIV-1 in patients. Founded in 1847, the company has a notable business presence
in the Middle East and Africa.
1. MIDDLE
EAST AND AFRICA DNA SEQUENCING MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE DNA SEQUENCING MARKET
2.2. KEY
INSIGHTS
2.2.1. APPLICATIONS
OF LIQUID BIOPSY
2.2.2. EMERGING
DEVELOPING ECONOMIES
2.2.3. DEVELOPMENT
IN PERSONALIZED MEDICINE AND BIOMARKER DISCOVERY
2.2.4. NEXT
GENERATION SEQUENCING
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. INDUSTRY
COMPONENTS
2.5. KEY
IMPACT ANALYSIS
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES
2.9. MARKET
DRIVERS
2.9.1. PREVALENCE
OF CANCER CASES
2.9.2. ADVANCEMENTS
IN TECHNOLOGY
2.9.3. APPLICATIONS
OF DNA SEQUENCING FOR ANIMALS & PLANTS REPRODUCTION
2.10. MARKET
RESTRAINTS
2.10.1. CHALLENGES
ASSOCIATED WITH DNA SEQUENCING TECHNOLOGIES IN BIOINFORMATICS
2.10.2. LACK
OF SKILLED PROFESSIONALS IN EMERGING ECONOMIES
2.10.3. LIMITATIONS
OF DNA SEQUENCING TECHNOLOGY IN DIAGNOSTIC TESTING
2.11. MARKET
OPPORTUNITIES
2.11.1. EXTENSIVE
RESEARCH AND DEVELOPMENT IN DNA SEQUENCING
2.11.2. GROWTH
IN GENOME MAPPING PROGRAMS
3. MIDDLE
EAST AND AFRICA DNA SEQUENCING MARKET – BY PRODUCT
3.1. INSTRUMENTS
& CONSUMABLES
3.1.1. INSTRUMENTS
& CONSUMABLES TYPE
3.1.1.1. CONSUMABLES
3.1.1.2. INSTRUMENTS
3.1.2. INSTRUMENTS
& CONSUMABLES PLATFORM
3.1.2.1. NGS
(NEXT GENERATION SEQUENCING)
3.1.2.1.1. RNA
SEQUENCING
3.1.2.1.2. TARGETED
RESEQUENCING
3.1.2.1.3. WHOLE-EXOME
SEQUENCING
3.1.2.1.4. WHOLE-GENOME
SEQUENCING
3.1.2.1.5. CHIP
SEQUENCING
3.1.2.1.6. DE
NOVO SEQUENCING
3.1.2.1.7. METHYL
SEQUENCING
3.1.2.2. SANGER
3.2. SEQUENCING
SERVICES
3.3. BIOINFORMATICS
4. MIDDLE
EAST AND AFRICA DNA SEQUENCING MARKET – BY TECHNOLOGY
4.1. SEQUENCING
BY SYNTHESIS
4.2. ION
SEMICONDUCTOR SEQUENCING
4.3. CHAIN
TERMINATION SEQUENCING
4.4. PYROSEQUENCING
4.5. SEQUENCING
BY LIGATION (SBL)
4.6. SINGLE-MOLECULE
REAL-TIME SEQUENCING (SMRT)
4.7. NANOPORE
SEQUENCING
4.8. OTHER
TECHNOLOGIES
5. MIDDLE
EAST AND AFRICA DNA SEQUENCING MARKET – BY APPLICATION
5.1. BIOMARKER
DISCOVERY
5.2. DIAGNOSTICS
5.3. REPRODUCTIVE
HEALTH
5.4. PERSONALIZED
MEDICINE
5.5. DRUG
DISCOVERY
5.6. AGRICULTURE
& ANIMAL RESEARCH
5.7. FORENSICS
5.8. OTHER
APPLICATIONS
6. MIDDLE
EAST AND AFRICA DNA SEQUENCING MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH
CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
6.2. PHARMACEUTICAL
6.3. BIOTECHNOLOGY
COMPANIES
6.4. HOSPITALS
& CLINICS
6.5. OTHER
INDUSTRY VERTICALS
7. MIDDLE
EAST AND AFRICA DNA SEQUENCING MARKET – COUNTRY OUTLOOK
7.1. SAUDI
ARABIA
7.2. UNITED
ARAB EMIRATES
7.3. TURKEY
7.4. SOUTH
AFRICA
7.5. REST
OF MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. ADAPTIVE
BIOTECHNOLOGIES INC
8.2. AGILENT
TECHNOLOGIES INC
8.3. ASURAGEN
INC
8.4. BGI
GENOMICS
8.5. BIO-RAD
LABORATORIES INC
8.6. DANAHER
CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
8.7. EUROFINS
SCIENTIFIC
8.8. F
HOFFMANN-LA ROCHE
8.9. ILLUMINA
INC
8.10. MERCK
KGAA
8.11. PACIFIC
BIOSCIENCES OF CALIFORNIA INC
8.12. PERKINELMER
INC
8.13. SIEMENS
HEALTHINEERS AG
8.14. SPIRAL
GENETICS INC
8.15. THERMO
FISHER SCIENTIFIC INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS, ANNOUNCEMENTS &
DIVESTITURES
TABLE 5: ACQUISITIONS & MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
TABLE 7: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND AFRICA INSTRUMENTS &
CONSUMABLES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA INSTRUMENTS &
CONSUMABLES MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA NGS MARKET, BY TYPE,
2021-2028 (IN $ MILLION)
TABLE 11: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 12: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 13: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 14: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)
FIGURE 2: LIMITATIONS OF DNA
SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 4: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $
MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA
INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA
INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA
INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA
NGS MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA
NGS MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA
NGS MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA
NGS MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA
NGS MARKET, BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA
NGS MARKET, BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA
NGS MARKET, BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA
INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 19: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $
MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $
MILLION)
FIGURE 22: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 23: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $
MILLION)
FIGURE 24: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT),
2021-2028 (IN $ MILLION)
FIGURE 25: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 26: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 27: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 28: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 29: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 30: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 31: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 33: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $
MILLION)
FIGURE 34: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 35: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 36: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 37: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT
INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 38: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)
FIGURE 39: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 40: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 41: MIDDLE EAST AND AFRICA
DNA SEQUENCING MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 42: SAUDI ARABIA DNA
SEQUENCING MARKET 2021-2028 ($ MILLION)
FIGURE 43: UNITED ARAB EMIRATES DNA
SEQUENCING MARKET 2021-2028 ($ MILLION)
FIGURE 44: TURKEY DNA SEQUENCING
MARKET 2021-2028 ($ MILLION)
FIGURE 45: SOUTH AFRICA DNA
SEQUENCING MARKET 2021-2028 ($ MILLION)
FIGURE 46: REST OF MIDDLE EAST &
AFRICA DNA SEQUENCING MARKET 2021-2028 ($ MILLION)